Loading...
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
THNR
THNR News & Events
-
Add to Watchlist
Trade THNR
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
News
THNR News
Hims & Hers, Eli Lilly, and Novo Nordisk Under FDA Review: Implications for Weight-Loss ETFs
Sep 18 2025
Benzinga
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit
Aug 19 2025
NASDAQ.COM
Amplify ETFs Achieves Landmark $10 Billion in Assets Under Management
Jan 15 2025
Globenewswire
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Dec 13 2024
Benzinga
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR
Oct 17 2024
NASDAQ.COM
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win
Oct 16 2024
NASDAQ.COM
Tap the Weight-Loss Drug Market With These ETFs
Sep 18 2024
NASDAQ.COM
5 ETFs to Make the Most of Eli Lilly's Strength
Aug 12 2024
NASDAQ.COM
Show More News
THNR Events
No data
THNR Monitor News
No data
THNR Earnings Analysis
No Data
People Also Watch
